PG
EW icon

PEAK6 Group’s Edwards Lifesciences EW Stock Holding History

PEAK6 Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$3.71M Sell
76,500
-51,300
-40% -$2.39M 0.02% 945
2018
Q1 		$5.94M Sell
127,800
-35,400
-22% -$1.54M 0.03% 716
2017
Q4 		$6.13M Buy
163,200
+158,100
+3,100% +$5.8M 0.03% 710
2017
Q3 		$186K Buy
5,100
+1,800
+55% +$68.7K ﹤0.01% 3354
2017
Q2 		$130K Sell
3,300
-4,500
-58% -$164K ﹤0.01% 3687
2017
Q1 		$245K Sell
7,800
-215,100
-97% -$6.73M ﹤0.01% 2908
2016
Q4 		$6.96M Sell
222,900
-900
-0.4% -$29.2K 0.05% 523
2016
Q3 		$8.99M Buy
223,800
+206,700
+1,209% +$7.78M 0.07% 388
2016
Q2 		$568K Sell
17,100
-162,300
-90% -$5.55M ﹤0.01% 2255
2016
Q1 		$5.28M Buy
179,400
+23,700
+15% +$654K 0.04% 583
2015
Q4 		$4.1M Sell
155,700
-12,300
-7% -$319K 0.03% 854
2015
Q3 		$3.98M Buy
168,000
+127,800
+318% +$3.08M 0.02% 1057
2015
Q2 		$954K Sell
40,200
-105,600
-72% -$2.38M 0.01% 2131
2015
Q1 		$3.46M Sell
145,800
-143,400
-50% -$3.22M 0.03% 899
2014
Q4 		$6.14M Sell
289,200
-219,600
-43% -$4.41M 0.05% 547
2014
Q3 		$8.66M Sell
508,800
-15,000
-3% -$237K 0.07% 377
2014
Q2 		$7.49M Buy
523,800
+438,000
+510% +$5.94M 0.07% 352
2014
Q1 		$1.06M Sell
85,800
-42,600
-33% -$492K 0.01% 1816
2013
Q4 		$1.41M Sell
128,400
-832,800
-87% -$9.39M 0.01% 1735
2013
Q3 		$5.58M Buy
961,200
+33,600
+4% +$393K 0.04% 674
2013
Q2 		$10.4K Buy
+927,600
New +$11M 0.04% 303

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PEAK6 Group's EW Position: Q2 2018 in Review

PEAK6 Group opened a new position in Edwards Lifesciences (EW) in Q2 2018: 5,466 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #3133 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in EW as recently as Q3 2017.

PEAK6 Group first reported a position in EW in Q2 2013 and has held it in 14 quarters since. The position peaked at $9.51M in Q4 2016. 838 funds tracked by Wall St. Rank hold EW as of Q2 2018.

  • PEAK6 Group held 5,466 shares of Edwards Lifesciences worth $265K as of Q2 2018.
  • Edwards Lifesciences was a new PEAK6 Group position in Q2 2018.
  • Edwards Lifesciences made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3133 holding.
  • PEAK6 Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 14 quarters since.
  • PEAK6 Group's Edwards Lifesciences position peaked at $9.51M in Q4 2016.
  • 838 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.